A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
김창곤, 홍민희, 김다희, Lee, Brian Hyohyoung, 김현욱, Ock, Chan-Young, Kelly, Geoffrey, Bang, Yoon Ji, 김가민, 이정은, Kim, Chaeyeon, 김세헌, 홍현준, 박영민, 심남석, 박희정, 박진우, 이창걸, 김경환, Park, Goeun, 정인경, 한다운, 김종훈, 차준하, 이인석, Kang, Mingu, Song, Heon, Oum, Chiyoon, Kim, Seulki, Kim, Sukjun, Lim, Yoojoo, Merad, Miriam, 윤선옥, Kim, Hyun Je, 고윤우, 김혜련, 김성희
Clinical Cancer Research, 2024